1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31757
Full metadata record
DC FieldValueLanguage
dc.contributor.authorItchins, Malinda-
dc.contributor.authorAinsworth, Hannah-
dc.contributor.authorAlexander, Marliese-
dc.contributor.authorDean, Samantha-
dc.contributor.authorDharmaraj, Devi-
dc.contributor.authorPavlakis, Nick-
dc.contributor.authorClarke, Stephen J-
dc.contributor.authorBrown, Chris-
dc.contributor.authorTorres, Javier-
dc.contributor.authorSaqib, Ayesha-
dc.contributor.authorLadwa, Rahul-
dc.contributor.authorO'Byrne, Kenneth-
dc.contributor.authorMoore, Melissa-
dc.contributor.authorYip, Po Yee-
dc.contributor.authorSolomon, Ben-
dc.contributor.authorJohn, Tom-
dc.contributor.authorKao, Steven-
dc.contributor.authorMitchell, Paul L R-
dc.contributor.authorParakh, Sagun-
dc.date2022-
dc.date.accessioned2023-01-12T02:52:54Z-
dc.date.available2023-01-12T02:52:54Z-
dc.date.issued2022-12-
dc.identifier.citationClinical Lung Cancer 2022; 23(8)en_US
dc.identifier.issn1938-0690-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31757-
dc.description.abstractThere are limited real world data on the IMpower150 regimen in oncogene driven tumors and central nervous system metastases; this study aims to address this gap.en_US
dc.language.isoeng-
dc.subjectEfficacyen_US
dc.subjectIMPower150en_US
dc.subjectReal worlden_US
dc.subjectToxicityen_US
dc.titleA Multi-Center Real-World Experience of IMpower150 in Oncogene Driven Tumors and CNS Metastases.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleClinical Lung Canceren_US
dc.identifier.affiliationMedical Oncology, Royal North Shore Hospital, The University of Sydney, St Leonards, New South Wales, Australia.en_US
dc.identifier.affiliationMedical Oncology, Royal North Shore Hospital, The University of Sydney, St Leonards, New South Wales, Australia.en_US
dc.identifier.affiliationPeter MacCallum Cancer Centre, The University of Melbourne, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationMedical Oncologyen_US
dc.identifier.affiliationMedical Oncology, Austin Health, La Trobe University, Heidelberg, Victoria, Australia.en_US
dc.identifier.affiliationMedical Oncology, Royal North Shore Hospital, The University of Sydney, St Leonards, New South Wales, Australia.en_US
dc.identifier.affiliationNHMRC Clinical Trials Centre, The University of Sydney, Camperdown, New South Wales, Australia.en_US
dc.identifier.affiliationGoulburn Valley Health, Shepparton, Victoria, Australia.en_US
dc.identifier.affiliationEpworth Healthcare, Richmond, Australia.en_US
dc.identifier.affiliationPrincess Alexandra Hospital, University of Queensland, Brisbane, Queensland, Australia.en_US
dc.identifier.affiliationSt. Vincent's Hospital, Fitzroy, Victoria, Australia.en_US
dc.identifier.affiliationMedical Oncology, Macarthur Cancer Therapy Centre, Campbelltown Hospital, Western Sydney University, Campbelltown, New South Wales, Australia.en_US
dc.identifier.affiliationPeter MacCallum Cancer Centre, The University of Melbourne, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationPeter MacCallum Cancer Centre, The University of Melbourne, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationMedical Oncology, Chris O'Brien Lifehouse, The University of Sydney, Camperdown, New South Wales, Australia.en_US
dc.identifier.doi10.1016/j.cllc.2022.07.016en_US
dc.type.contentTexten_US
dc.identifier.pubmedid36030187-
dc.description.volume23-
dc.description.issue8-
dc.description.startpage702-
dc.description.endpage708-
dc.subject.meshtermssecondaryCarcinoma, Non-Small-Cell Lung/drug therapy-
dc.subject.meshtermssecondaryCarcinoma, Non-Small-Cell Lung/genetics-
dc.subject.meshtermssecondaryErbB Receptors/genetics-
dc.subject.meshtermssecondaryLung Neoplasms/drug therapy-
dc.subject.meshtermssecondaryLung Neoplasms/genetics-
dc.subject.meshtermssecondaryCentral Nervous System Neoplasms/drug therapy-
dc.subject.meshtermssecondaryCentral Nervous System Neoplasms/genetics-
dc.subject.meshtermssecondaryMutation/genetics-
dc.subject.meshtermssecondaryBrain Neoplasms/drug therapy-
dc.subject.meshtermssecondaryBrain Neoplasms/genetics-
dc.subject.meshtermssecondaryBrain Neoplasms/pathology-
dc.subject.meshtermssecondaryNeoplasms, Second Primary/genetics-
local.name.researcherJohn, Thomas
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptMedical Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptMedical Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptMedical Oncology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

56
checked on Nov 24, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.